These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21928121)

  • 1. Interferon regulatory factor (IRF)-5: a potential therapeutic target for ankylosing spondylitis.
    Xu WD; Ye DQ
    Rheumatol Int; 2012 Dec; 32(12):4065-7. PubMed ID: 21928121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankylosing spondylitis.
    Braun J; Sieper J
    Lancet; 2007 Apr; 369(9570):1379-1390. PubMed ID: 17448825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission in ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-88-92. PubMed ID: 17083769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
    van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ankylosing spondylitis.
    Clegg DO
    J Rheumatol Suppl; 2006 Sep; 78():24-31. PubMed ID: 17042057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification.
    Sari I; Haroon N
    Curr Rheumatol Rep; 2018 Nov; 20(12):82. PubMed ID: 30406859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
    Pham T; Landewé R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D
    Ann Rheum Dis; 2006 Dec; 65(12):1620-5. PubMed ID: 16464984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial.
    Haibel H; Brandt HC; Song IH; Brandt A; Listing J; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2007 Mar; 66(3):419-21. PubMed ID: 16901959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
    Ogdie A; de Vlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Gruben D; Kwok K; Wang C; Hsu MA; Maniccia A
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
    Madsen OR; Egsmose C
    Ugeskr Laeger; 2009 Aug; 171(33):2268-72. PubMed ID: 19732504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of ankylosing spondylitis.
    Rudwaleit M; Sieper J
    Expert Opin Biol Ther; 2005 Aug; 5(8):1095-109. PubMed ID: 16050786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of biologic agents in the therapy of ankylosing spondylitis].
    Géher P; Nagy MB; Péntek M; Tóth E; Brodszky V; Gulácsi L
    Orv Hetil; 2006 Jul; 147(26):1203-13. PubMed ID: 16898082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.
    Poddubnyy D; Song IH; Sieper J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S148-51. PubMed ID: 19822063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature.
    Rocha FAC; Pinto ACMD; Lopes JR; Deodhar A
    Clin Rheumatol; 2021 May; 40(5):1881-1887. PubMed ID: 33230684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spondyloarthritides].
    Rudwaleit M
    Internist (Berl); 2017 Jul; 58(7):687-701. PubMed ID: 28593426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus development on eligibility of government subsidisation of biologic disease modifying anti-rheumatic agents for treatment of ankylosing spondylitis: The Singapore experience.
    Cheung PP; Lahiri M; Teng GG; Lui NL; Chia FL; Koh DR; Koh WH; Ng SC; Suresh E; Leong KP; Lim AYN; Thumboo J; Lau TC; Leong KH
    Int J Rheum Dis; 2017 Oct; 20(10):1517-1526. PubMed ID: 26177789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfasalazine for ankylosing spondylitis.
    Chen J; Lin S; Liu C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD004800. PubMed ID: 25427435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.